Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Nat Med ; 5(4): 439-43, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10202936

ABSTRACT

Limb-girdle muscular dystrophies 2C-F represent a family of autosomal recessive diseases caused by defects in sarcoglycan genes. The cardiomyopathic hamster is a naturally occurring model for limb-girdle muscular dystrophy caused by a primary deficiency in delta-sarcoglycan. We show here that acute sarcolemmal disruption occurs in this animal model during forceful muscle contraction. A recombinant adeno-associated virus vector encoding human delta-sarcoglycan conferred efficient and stable genetic reconstitution in the adult cardiomyopathic hamster when injected directly into muscle. A quantitative assay demonstrated that vector-transduced muscle fibers are stably protected from sarcolemmal disruption; there was no associated inflammation or immunologic response to the vector-encoded protein. Efficient gene transduction with rescue of the sarcoglycan complex in muscle fibers of the distal hindlimb was also obtained after infusion of recombinant adeno-associated virus into the femoral artery in conjunction with histamine-induced endothelial permeabilization. This study provides a strong rationale for the development of gene therapy for limb-girdle muscular dystrophy.


Subject(s)
Cytoskeletal Proteins/therapeutic use , Genetic Therapy/methods , Histamine/therapeutic use , Membrane Glycoproteins/therapeutic use , Muscular Dystrophy, Animal/therapy , Animals , Cell Membrane Permeability , Cricetinae , Cytoskeletal Proteins/genetics , Dependovirus/genetics , Genetic Vectors , Humans , Membrane Glycoproteins/genetics , Perfusion , Rats , Rats, Inbred F344 , Recombinant Proteins/therapeutic use , Sarcoglycans , Sarcolemma/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...